176 related articles for article (PubMed ID: 21911794)
1. Minimizing the renal toxicity of iodinated contrast.
McCullough PA; Khambatta S; Jazrawi A
Circulation; 2011 Sep; 124(11):1210-1. PubMed ID: 21911794
[No Abstract] [Full Text] [Related]
2. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
[TBL] [Abstract][Full Text] [Related]
3. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
[TBL] [Abstract][Full Text] [Related]
4. Forced diuresis with matched hydration in reducing acute kidney injury during transcatheter aortic valve implantation (Reduce-AKI): study protocol for a randomized sham-controlled trial.
Arbel Y; Ben-Assa E; Halkin A; Keren G; Schwartz AL; Havakuk O; Leshem-Rubinow E; Konigstein M; Steinvil A; Abramowitz Y; Finkelstein A; Banai S
Trials; 2014 Jul; 15():262. PubMed ID: 24986373
[TBL] [Abstract][Full Text] [Related]
5. [Acute renal failure caused by contrast - as is always the most important prevention].
Bryniarski L
Kardiol Pol; 2010 Sep; 68(9):1021-2. PubMed ID: 20859893
[No Abstract] [Full Text] [Related]
6. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
ACT Investigators
Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972
[TBL] [Abstract][Full Text] [Related]
7. [Acute Kidney Injury, AKI - Update 2018].
Patschan D; Müller GA
Dtsch Med Wochenschr; 2018 Aug; 143(15):1094-1096. PubMed ID: 30060280
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine fails to prevent renal dysfunction and oxidative stress after noniodine contrast media administration during percutaneous coronary interventions.
Buyukhatipoglu H; Sezen Y; Yildiz A; Bas M; Kirhan I; Ulas T; Turan MN; Taskin A; Aksoy N
Pol Arch Med Wewn; 2010 Oct; 120(10):383-9. PubMed ID: 20980943
[TBL] [Abstract][Full Text] [Related]
9. Radiocontrast-induced acute renal failure.
Weisbord SD; Palevsky PM
J Intensive Care Med; 2005; 20(2):63-75. PubMed ID: 15855219
[TBL] [Abstract][Full Text] [Related]
10. Q: Should N-acetylcysteine be used routinely to prevent contrast-induced acute kidney injury?
Sivalingam SK; Hariharan MV; Braden GL; Freda BJ
Cleve Clin J Med; 2012 Nov; 79(11):746-9. PubMed ID: 23125323
[No Abstract] [Full Text] [Related]
11. Acute kidney injury: Antioxidants do not PRESERVE kidney function after contrast exposure.
Solomon R
Nat Rev Nephrol; 2018 Mar; 14(3):148-149. PubMed ID: 29355174
[No Abstract] [Full Text] [Related]
12. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
13. AKIGUARD (Acute Kidney Injury GUARding Device) trial: in-hospital and one-year outcomes.
Usmiani T; Andreis A; Budano C; Sbarra P; Andriani M; Garrone P; Fanelli AL; Calcagnile C; Bergamasco L; Biancone L; Marra S
J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):530-7. PubMed ID: 26702595
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention.
Seyon RA; Jensen LA; Ferguson IA; Williams RG
Heart Lung; 2007; 36(3):195-204. PubMed ID: 17509426
[TBL] [Abstract][Full Text] [Related]
15. Are we still wondering or wandering in the dark?
Cattano D
Intern Emerg Med; 2011 Dec; 6(6):485-6. PubMed ID: 21416287
[No Abstract] [Full Text] [Related]
16. Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions.
Wróbel W; Sinkiewicz W; Gordon M; Woźniak-Wiśniewska A
Kardiol Pol; 2010 Sep; 68(9):1015-20. PubMed ID: 20859892
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
[TBL] [Abstract][Full Text] [Related]
18. Contrast-induced Nephropathy: Essentials and Concerns.
Samadian F; Dalili N; Mahmoudieh L; Ziaei S
Iran J Kidney Dis; 2018 May; 12(3):135-141. PubMed ID: 29891742
[TBL] [Abstract][Full Text] [Related]
19. Removal of contrast media from the coronary sinus attenuates renal injury after coronary angiography and intervention.
Duffy SJ; Ruygrok P; Juergens CP; Sievert H; Richards M; Blake J; Whitbourn R; Farouque HO; Pertile T; Kaye DM
J Am Coll Cardiol; 2010 Aug; 56(6):525-6. PubMed ID: 20670766
[No Abstract] [Full Text] [Related]
20. A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention.
Shemirani H; Pourrmoghaddas M
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):280-5. PubMed ID: 22382219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
